JN Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 97: 3713-3721, 2007. First published March 28, 2007; doi:10.1152/jn.00841.2006
0022-3077/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
97/5/3713    most recent
00841.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasilyev, D. V.
Right arrow Articles by Dunlop, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasilyev, D. V.
Right arrow Articles by Dunlop, J.

Direct Inhibition of Ih by Analgesic Loperamide in Rat DRG Neurons

Dmitry V. Vasilyev1, Qin Shan1, Yan Lee1, Scott C. Mayer2, Mark R. Bowlby1, Brian W. Strassle1, Edward J. Kaftan1, Kathryn E. Rogers1 and John Dunlop1

1Discovery Neuroscience and 2Chemical and Screening Sciences, Wyeth Research, Princeton, New Jersey

Submitted 10 August 2006; accepted in final form 18 March 2007

Hyperpolarization-activated cyclic nucleotide–gated (HCN) channels are responsible for the functional hyperpolarization-activated current (Ih) in dorsal root ganglion (DRG) neurons, playing an important role in pain processing. We found that the known analgesic loperamide inhibited Ih channels in rat DRG neurons. Loperamide blocked Ih in a concentration-dependent manner, with an IC50 = 4.9 ± 0.6 and 11.0 ± 0.5 µM for large- and small-diameter neurons, respectively. Loperamide-induced Ih inhibition was unrelated to the activation of opioid receptors and was reversible, voltage-dependent, use-independent, and was associated with a negative shift of V1/2 for Ih steady-state activation. Loperamide block of Ih was voltage-dependent, gradually decreasing at more hyperpolarized membrane voltages from 89% at –60 mV to 4% at –120 mV in the presence of 3.7 µM loperamide. The voltage sensitivity of block can be explained by a loperamide-induced shift in the steady-state activation of Ih. Inclusion of 10 µM loperamide into the recording pipette did not affect Ih voltage for half-maximal activation, activation kinetics, and the peak current amplitude, whereas concurrent application of equimolar external loperamide produced a rapid, reversible Ih inhibition. The observed loperamide-induced Ih inhibition was not caused by the activation of peripheral opioid receptors because the broad-spectrum opioid receptor antagonist naloxone did not reverse Ih inhibition. Therefore we suggest that loperamide inhibits Ih by direct binding to the extracellular region of the channel. Because Ih channels are involved in pain processing, loperamide-induced inhibition of Ih channels could provide an additional molecular mechanism for its analgesic action.


Address for reprint requests and other correspondence: D. Vasilyev, Discovery Neuroscience, Wyeth Research, CN 8000, Princeton, NJ 08543-8000 (E-mail: vasylyd{at}wyeth.com)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the The American Physiological Society.